Biote Share Price (NASDAQ: BTMD)

$3.45

▲

-0.02

(-0.58%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Biote Stock chart to analyse performance

Biote stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$3.41
Today's High:$3.51
$3.45
1.16%
Downside
Day's Volatility :2.85%
Upside
1.71%
52 Weeks Low:$2.76
52 Weeks High:$6.98
$3.45
20.0%
Downside
52 Weeks Volatility :60.46%
Upside
50.57%

Biote Stock Returns

Period	Biote Corp	Index (Russel 2000)
3 Months	-2.54%	0.0%
6 Months	-18.63%	0.0%
1 Year	-42.4%	0.0%
3 Years	-18.63%	-4.7%

Biote Corp Key Stats

Check Biote key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$3.47
Open	$3.505
Today's High	$3.51
Today's Low	$3.41
Market Capitalization	$166.0M
Today's Volume	$157.1K
52 Week High	$6.98
52 Week Low	$2.76
Revenue TTM	$199.1M
EBITDA	$41.4M
Earnings Per Share (EPS)	$0.88
PE Ratio	3.94
Profit Margin	15.73%
Quarterly Earnings Growth YOY	-0.17%
Return On Equity TTM	0.0%

Stock Returns calculator for Biote Stock including INR - Dollar returns

The Biote stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Biote investment value today

Current value as on today

₹62,880

Returns

₹37,120

(-37.12%)

Returns from Biote Stock

₹42,404 (-42.4%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Biote Stock

-52%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Biote Stock from India on INDmoney has decreased by -52% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Biote Corp

Name
Holdings %
Name
Holdings %
325 Capital LLC
14.35%
Bandera Partners LLC
7.21%
BlackRock Inc
5.44%
Vanguard Group Inc
4.49%
Acadian Asset Management LLC
2.21%
Dimensional Fund Advisors, Inc.
1.95%

Analyst Recommendation on Biote Stock

Rating

Trend

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Biote(by analysts ranked 0 to 5 stars)

Biote Share Price Target

What analysts predicted

Upside of 41.57%

Target:

$4.88

Current:

$3.45

Biote share price target is $4.88, a slight Upside of 41.57% compared to current price of $3.45 as per analysts' prediction.

Biote Stock Insights

Price Movement
In the last 7 days, BTMD stock has moved up by 7.1%
Decreasing Revenue
Revenue is down for the last 4 quarters, 51.38M → 48.86M (in $), with an average decrease of 1.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 13.71M → 3.18M (in $), with an average decrease of 76.8% per quarter
BTMD vs FMS (1 yr)
In the last 1 year, Fresenius Medical Care Ag has given 32.5% return, outperforming this stock by 77.6%
Price to Sales
ForBTMD every $1 of sales, investors are willing to pay $0.6, whereas for Fresenius Medical Care Ag, the investors are paying $0.8 for every $1 of sales.

Biote Corp Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$110.0M	-
Net Income	$21.3M	-
Net Profit Margin	19.36%	-

	FY20	Y/Y Change
Revenue	$116.6M	↑ 5.99%
Net Income	$29.2M	↑ 36.99%
Net Profit Margin	25.02%	↑ 5.66%

	FY21	Y/Y Change
Revenue	$139.4M	↑ 19.58%
Net Income	$32.6M	↑ 11.85%
Net Profit Margin	23.4%	↓ 1.62%

	FY22	Y/Y Change
Revenue	$165.0M	↑ 18.34%
Net Income	$1.3M	↓ 95.94%
Net Profit Margin	0.8%	↓ 22.6%

	FY23	Y/Y Change
Revenue	$185.4M	↑ 12.37%
Net Income	$3.3M	↑ 150.45%
Net Profit Margin	1.79%	↑ 0.99%

	FY24	Y/Y Change
Revenue	$197.2M	↑ 6.38%
Net Income	$3.2M	↓ 4.79%
Net Profit Margin	1.6%	↓ 0.19%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$46.8M	↑ 2.41%
Net Income	$-2.1M	↓ 126.76%
Net Profit Margin	-4.42%	↓ 21.34%

	Q2 FY24	Q/Q Change
Revenue	$49.2M	↑ 5.05%
Net Income	$-6.3M	↑ 205.41%
Net Profit Margin	-12.86%	↓ 8.44%

	Q3 FY24	Q/Q Change
Revenue	$51.4M	↑ 4.5%
Net Income	$10.7M	↓ 269.28%
Net Profit Margin	20.83%	↑ 33.69%

	Q4 FY24	Q/Q Change
Revenue	$49.8M	↓ 3.02%
Net Income	$3.7M	↓ 65.4%
Net Profit Margin	7.43%	↓ 13.4%

	Q1 FY25	Q/Q Change
Revenue	$49.0M	↓ 1.69%
Net Income	$13.7M	↑ 270.46%
Net Profit Margin	28.0%	↑ 20.57%

	Q2 FY25	Q/Q Change
Revenue	$48.9M	↓ 0.26%
Net Income	$3.2M	↓ 76.78%
Net Profit Margin	6.52%	↓ 21.48%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$66.4M	-

	FY20	Y/Y Change
Profit	$71.6M	↑ 7.87%

	FY21	Y/Y Change
Profit	$90.6M	↑ 26.44%

	FY22	Y/Y Change
Profit	$110.4M	↑ 21.86%

	FY23	Y/Y Change
Profit	$127.5M	↑ 15.49%

	FY24	Y/Y Change
Profit	$139.1M	↑ 9.08%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$32.7M	↑ 8.28%

	Q2 FY24	Q/Q Change
Profit	$33.9M	↑ 3.66%

	Q3 FY24	Q/Q Change
Profit	$36.2M	↑ 6.88%

	Q4 FY24	Q/Q Change
Profit	$35.5M	↓ 1.88%

	Q1 FY25	Q/Q Change
Profit	$36.4M	↑ 2.4%

	Q2 FY25	Q/Q Change
Profit	$35.0M	↓ 3.83%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$25.4M	-
Investing Cash Flow	$-1.7M	-
Financing Cash Flow	$-13.6M	-

	FY20	Y/Y Change
Operating Cash Flow	$26.4M	↑ 4.22%
Investing Cash Flow	$-1.4M	↓ 16.69%
Financing Cash Flow	$-18.3M	↑ 35.17%

	FY21	Y/Y Change
Operating Cash Flow	$33.7M	↑ 27.61%
Investing Cash Flow	$-3.8M	↑ 173.3%
Financing Cash Flow	$-20.3M	↑ 11.05%

	FY22	Y/Y Change
Operating Cash Flow	$-9.2M	↓ 127.16%
Investing Cash Flow	$-1.8M	↓ 51.72%
Financing Cash Flow	$63.5M	↓ 411.95%

	FY23	Y/Y Change
Operating Cash Flow	$26.9M	↓ 393.58%
Investing Cash Flow	$-2.7M	↑ 47.61%
Financing Cash Flow	$-14.4M	↓ 122.66%

	FY24	Y/Y Change
Operating Cash Flow	$45.2M	↑ 68.3%
Investing Cash Flow	$-18.8M	↑ 592.89%
Financing Cash Flow	$-76.1M	↑ 429.09%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$7.4M	↑ 5.98%
Investing Cash Flow	$-12.2M	↓ 164.1%
Financing Cash Flow	$-5.4M	↑ 114.22%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$9.9M	↑ 34.93%
Investing Cash Flow	$-3.3M	↓ 72.59%
Financing Cash Flow	$-59.0M	↑ 990.26%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$15.6M	↑ 56.39%
Investing Cash Flow	$-2.0M	↓ 40.85%
Financing Cash Flow	$-1.8M	↓ 97.0%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$12.4M	↓ 20.49%
Investing Cash Flow	$-1.3M	↓ 33.59%
Financing Cash Flow	$-9.9M	↑ 461.88%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$6.5M	↓ 47.71%
Investing Cash Flow	$-1.8M	↑ 40.96%
Financing Cash Flow	$-2.3M	↓ 77.28%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$7.1M	↑ 9.57%
Investing Cash Flow	$-2.0M	↑ 6.17%
Financing Cash Flow	$-27.2M	↑ 1106.56%

Biote Technicals Summary

Sell

Neutral

Buy

Biote is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Biote Corp Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Biote Corp	-15.23%	-18.63%	-42.4%	-18.63%	-18.63%
Fresenius Medical Care Ag	1.42%	9.13%	33.85%	52.16%	-38.9%
Hca Holdings, Inc.	14.02%	29.66%	1.97%	102.37%	200.76%
Encompass Health Corporation	10.53%	21.96%	30.5%	149.95%	85.63%
Universal Health Services Inc.	9.12%	3.32%	-23.19%	86.77%	64.27%
Tenet Healthcare Corp.	14.28%	47.97%	14.02%	226.96%	548.52%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Biote Corp	3.94	3.94	NA	0.5	0.0	0.25	NA	-2.68
Fresenius Medical Care Ag	19.34	19.34	0.42	1.96	0.06	0.03	0.03	45.23
Hca Holdings, Inc.	16.98	16.98	1.32	26.34	1.36	0.12	0.01	-18.61
Encompass Health Corporation	23.73	23.73	NA	5.28	0.25	0.09	0.01	22.6
Universal Health Services Inc.	9.57	9.57	1.87	20.44	0.19	0.08	0.0	110.47
Tenet Healthcare Corp.	11.59	11.59	0.85	15.81	0.3	0.08	NA	42.44

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Biote Corp	Buy	$166.0M	-18.63%	3.94	15.73%
Fresenius Medical Care Ag	Hold	$14.8B	-38.9%	19.34	3.36%
Hca Holdings, Inc.	Buy	$95.3B	200.76%	16.98	8.21%
Encompass Health Corporation	Buy	$12.4B	85.63%	23.73	9.22%
Universal Health Services Inc.	Hold	$11.6B	64.27%	9.57	7.66%
Tenet Healthcare Corp.	Buy	$16.3B	548.52%	11.59	7.18%

About Biote Corp

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.

Organization	Biote
Employees	217
CEO	Mr. Bret Christensen
Industry	Miscellaneous

Key Management of Biote Corp

Name	Title
Mr. Marc D. Beer	Executive Chairman
Mr. Robert C. Peterson	Chief Financial Officer
Mr. Bret Christensen	CEO & Director
Mr. John J. Olsen	Chief Information Officer
Ms. Mary Elizabeth Conlon	VP of Business Development, General Counsel & Corporate Secretary
Mr. Joel Pickering	Chief Marketing Officer
Mr. Richard Kevin Key	Chief Digital Officer
Mr. Jade Beutler	Head of Nutraceuticals
Dr. Cory Rice D.O.	Chief Clinical Advisor & Member of Medical Advisory Board

Important FAQs about investing in BTMD Stock from India :

What is Biote share price today?

Biote share price today is $3.45 as on August 30, 2025 at 1:29 am IST at the close of the market. Biote share today touched a day high of $3.51 and a low of $3.41.

What is the 52 week high and 52 week low for Biote share?

Biote share touched a 52 week high of $6.98 and a 52 week low of $2.76. Biote stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $3.45, lower by 50.57% versus the 52 week high.

How to invest in Biote Stock (BTMD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Biote on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biote Shares that will get you 0.4348 shares as per Biote share price of $3.45 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Biote Stock (BTMD) from India?

Indian investors can start investing in Biote (BTMD) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Biote stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Biote share’s latest price of $3.45 as on August 30, 2025 at 1:29 am IST, you will get 2.8986 shares of Biote. Learn more about fractional shares .

What are the returns that Biote has given to Indian investors in the last 5 years?

Biote stock has given -18.63% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?